These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [Abstract] [Full Text] [Related]
7. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Leone N, Rizzetto M. Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144 [Abstract] [Full Text] [Related]
8. Chronic liver disease and hepatitis C virus in Egyptian patients. El-Medany OM, El-Din Abdel Wahab KS, Abu Shady EA, Gad El-Hak N. Hepatogastroenterology; 1999 Mar; 46(27):1895-903. PubMed ID: 10430366 [Abstract] [Full Text] [Related]
9. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma. Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Watanabe N. Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150 [Abstract] [Full Text] [Related]
14. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D. Z Gastroenterol; 1997 Dec 15; 35(12):1059-67. PubMed ID: 9487638 [Abstract] [Full Text] [Related]
15. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R. Hepatology; 1996 Jun 15; 23(6):1304-12. PubMed ID: 8675143 [Abstract] [Full Text] [Related]
16. Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India. Ramesh R, Munshi A, Panda SK. J Gastroenterol Hepatol; 1992 Jun 15; 7(4):393-5. PubMed ID: 1325197 [Abstract] [Full Text] [Related]
17. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study]. Perret JL, Moussavou-Kombila JB, Delaporte E, Pemba LF, Boguikouma JB, Matton T, Larouze B. Gastroenterol Clin Biol; 2002 Feb 15; 26(2):131-5. PubMed ID: 11938063 [Abstract] [Full Text] [Related]
18. Apoptosis in hepatitis C virus infection. Bantel H, Schulze-Osthoff K. Cell Death Differ; 2003 Jan 15; 10 Suppl 1():S48-58. PubMed ID: 12655346 [Abstract] [Full Text] [Related]
19. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K, Pal NS, Arora SK. Indian J Pathol Microbiol; 2006 Jul 15; 49(3):357-61. PubMed ID: 17001884 [Abstract] [Full Text] [Related]
20. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM, Shiha GE, Ismail H, Mansy SE, El-Sherbiny R, El-Dosoky I. Clin Biochem; 2009 Apr 15; 42(6):455-61. PubMed ID: 19063876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]